Company news
Tanvex Biopharma, Inc. (TWSE:6541) news
Tanvex Biopharma, Inc. news releases on 6ix. Latest, Aug 15, 2022: Tanvex BioPharma : Represent subsidiary Tanvex BioPharma USA,Inc. to announce BLA…
Press releases & updates
Tanvex BioPharma : Represent subsidiary Tanvex BioPharma USA,Inc. to announce BLA resubmission for TX01(Neupogen Biosimilar)
August 15, 2022
Tanvex BioPharma : The Company has been required by TWSE to announce the financial data according to the regulations
August 4, 2022
Tanvex BioPharma : Represent subsidiary Tanvex BioPharma USA,Inc. to announce the result of FDA inspection for TX05(Herceptin Biosimilar)(supplementary)
August 1, 2022
Tanvex BioPharma : Represent subsidiary Tanvex BioPharma USA,Inc. to announce the result of FDA inspection for TX05(Herceptin Biosimilar)
July 31, 2022
Tanvex BioPharma : Represent subsidiary Tanvex BioPharma USA,Inc. to announce that TX01(Neupogen Biosimilar) got Drug Establishment Licence from Health Canada
July 24, 2022
Tanvex BioPharma : Announcement of the Board of Directors' resolution on the appointment of corporate governance officer
July 15, 2022
Tanvex BioPharma : Announcement of new appointment of the Company's Remuneration Committee.
July 15, 2022
Tanvex BioPharma : The Announcement of Resolutions of 2022 Annual General Shareholders’ Meeting(Add any other proposals)
June 17, 2022
Tanvex BioPharma : Announcement of the Resolution of Annual General Meeting to Approve of Lifting of Non-Competition Restrictions for Board Director.
June 17, 2022
Tanvex BioPharma : Announcement of One Newly By-Elected Independent Director at 2022 General Shareholders' Meeting of Tanvex
June 17, 2022
Tanvex BioPharma : The Announcement of Resolutions of 2022 Annual General Shareholders’ Meeting
June 17, 2022
Tanvex BioPharma : The Board of Directors approved the convening of the 2022 Annual General Shareholders' Meeting(add new discussion matters)
April 22, 2022
Tanvex BioPharma : Resolution by the board of directors not to distribute dividends
March 21, 2022
Tanvex BioPharma : The time, venue, and agenda of the 2022 annual general meeting.
March 21, 2022
Tanvex BioPharma : The Board approved to issue Employees' Restricted Share Award
March 21, 2022
Tanvex BioPharma : Appointment of the Chief Executive Officer and Chief Financial Officer (CFO)/Accounting officer
February 18, 2022